Duke-NUS Researchers Uncover Molecular Switch Governing Pancreatic Cancer Treatment Response
Hendra Lukman Singapore – In a significant breakthrough for oncology research, scientists at Duke-NUS Medical School have...
Hematology, Leukemia & Lymphoma
New Large-Scale Study Suggests Vitamin D Supplements May Offer Hope for Long COVID, Though Not for Acute Infection Severity
A comprehensive, randomized controlled trial, one of the most extensive and rigorously designed to date,...
Midlife Vitamin D Levels Linked to Lower Brain Tau Protein Years Later
A groundbreaking study published on April 1, 2026, in Neurology Open Access, the esteemed official...
Duke Researchers Uncover Key Enzyme for Multiple Myeloma Treatment, Opening New Avenues for Therapy
Researchers at Duke University have identified a critical enzyme involved in iron regulation that not...
A Simple Vitamin D Supplement Shows Promise in Enhancing Breast Cancer Chemotherapy Effectiveness in Brazilian Study
Researchers at the Botucatu School of Medicine at São Paulo State University (FMB-UNESP) in Brazil...
The Unexpected Role of Vitamin B2 in Shielding Cancer Cells from Death
A pivotal nutrient essential for human health, Vitamin B2, also known as riboflavin, has been...
New Research Suggests Vitamin D2 Supplements May Undermine the Body’s More Effective Vitamin D3 Levels
New research emerging from a collaborative effort between the University of Surrey, the John Innes...
Vitamin K Analogues Show Promise in Regenerating Lost Brain Cells for Neurodegenerative Diseases
Diseases such as Alzheimer’s, Parkinson’s, and Huntington’s represent a devastating hallmark of aging and neurological...
Vitamin D2 Supplements May Undermine Body’s Levels of More Potent Vitamin D3, New Research Reveals
New findings from a collaborative effort involving the University of Surrey, the John Innes Centre,...
A New Era of Pandemic Preparedness: AI-Designed Universal Coronavirus Vaccine Achieves Safety Milestone in First Human Trial
The landscape of infectious disease defense may be on the cusp of a paradigm shift...
